SuperSonic Imagine
RELATED CONTENT
Physicians have been utilizing conventional ultrasound, also known as b-mode ultrasound, for diagnostic imaging since the 1970s. However, over the past 10 years there have been significant technological improvements within the equipment, as well as development of new technologies that allowed ultrasound to become more widely adopted. Ultrasound equipment has gotten physically smaller, generates less heat and has become more power efficient. These upgrades, along with vast enhancements in image quality, have pushed ultrasound into the point-of-care setting. Point-of-care ultrasound has become widely performed in emergency rooms, PCP offices and obstetric practices. As healthcare reform continues to favor the use of more cost-effective solutions, this trend is expected to persist until ultrasound is used in every doctor’s office.
November 04, 2013 
SuperSonic Imagine’s Aixplorer MultiWave Ultrasound system, first cleared by the U.S. Food and Drug Administration (FDA) in 2009, has received FDA clearance for the quantification capabilities of its Real-Time ShearWave Elastography (SWE).
October 01, 2013
October 11, 2012 — SuperSonic Imagine announced it has received U.S. Food and Drug Administration (FDA) clearance for the addition of a real-time, adjustable numerical scale (ANS) in meters per second for ShearWave Elastography (SWE) on the Aixplorer.
October 11, 2012
March 5, 2012 — Results of the largest clinical breast study sponsored by an ultrasound manufacturer have recently been published in the peer-reviewed Radiology and European Radiology medical journals. The multinational, multicenter “Breast Elastography 1 (BE1)” study assessed the clinical benefits of ShearWave Elastography (SWE) in the ultrasonic diagnosis of breast lesions.
March 05, 2012
August 26, 2009 - SuperSonic Imagine announced today the FDA has granted 510(k) clearance for its Aixplorer ultrasound system and will begin to market and deliver the device in the United States.
August 26, 2009